Subscribe to RSS

DOI: 10.1055/s-0045-1810049
The Awareness of the Jordanian Population Regarding Intranasal Corticosteroids' Uses for Allergic Rhinitis
Authors
Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Abstract
Introduction
Intranasal corticosteroids are widely regarded as the most efficacious remedy for managing moderate to severe allergic rhinitis. However, the Jordanian population's understanding and attitudes toward the safe and proper use of these medications remain ambiguous.
Objective
This study was undertaken to evaluate Jordanian individuals' awareness of intranasal corticosteroids by examining their present perceptions, attitudes, and behaviors regarding these pharmaceuticals.
Methods
We conducted a cross-sectional study within the adult Jordanian demographic using an online survey based on a structured questionnaire.
Results
The study comprised 1509 participants, revealing that 34.2% of the adult Jordanian population suffers from allergic rhinitis, with a prevalence of 39.5% in males and 60.5% in females. Among individuals with allergic rhinitis, 34.1%, 38.4%, 67.1%, and 43.2% hold beliefs regarding the impact of intranasal corticosteroids on blood sugar, blood pressure, pregnancy, and obesity, respectively. Notably, 67.8% of allergic rhinitis patients in our study actively use intranasal corticosteroids, and users demonstrate a significantly higher level of awareness compared with non-users, as we found significantly higher awareness levels among allergic rhinitis patients regarding possible side effects compared with non-allergic rhinitis group (p-value = < .0001, 0.0019, 0.0109, <.0001 and 0.0034) for blood sugar, blood pressure, pregnancy, children less than 5 years and obesity respectively.
Conclusion
The results obtained from this research underscore the critical need for educational initiatives and interventions to enhance understanding and utilization of these medications within Jordan. These efforts can significantly contribute to improved patient outcomes and decreased healthcare expenses.
Authors' Contributions
HIA, AK: conceptualization, methodology, data collection, data interpretation, writing – review & editing; TAO, RIA, BHA, LMA, RNB, MAA: data collection, manuscript preparation; HIA, AK: contributed equally to the manuscript. All authors have read and approved the final version of the manuscript.
Data Availability Statement
Data supporting the results of this study are available upon a reasonable request from the corresponding author.
Publication History
Received: 24 May 2024
Accepted: 19 June 2025
Article published online:
16 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Hasan Ibrahim Al-Balas, Almu'atasim Khamees, Tala Abd Aljaleel Okour, Ruaa Ismail Ababneh, Bara' Hussein Al-Smadi, Leen Mohamad Almomani, Reem Nazem BaniHani, Marah Akram AlRawashdeh. The Awareness of the Jordanian Population Regarding Intranasal Corticosteroids' Uses for Allergic Rhinitis. Int Arch Otorhinolaryngol 2025; 29: s00451810049.
DOI: 10.1055/s-0045-1810049
-
References
- 1 Savouré M, Bousquet J, Jaakkola JJK, Jaakkola MS, Jacquemin B, Nadif R. Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolution. Clin Transl Allergy 2022; 12 (03) e12130
- 2 Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS. WAO white book on allergy. Milwaukee, WI: World Allergy Organization. 2011;3:156–7.
- 3 Ciprandi G, Klersy C, Cirillo I, Marseglia GL. Quality of life in allergic rhinitis: relationship with clinical, immunological, and functional aspects. Clin Exp Allergy 2007; 37 (10) 1528-1535
- 4 Aburuz S, Bulatova N, Tawalbeh M. Skin prick test reactivity to aeroallergens in Jordanian allergic rhinitis patients. East Mediterr Health J 2011; 17 (07) 604-610
- 5 Bousquet J, Anto JM, Bachert C. et al. Allergic rhinitis. Nat Rev Dis Primers 2020; 6 (01) 95
- 6 Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999; 20 (04) 209-213
- 7 Tran NP, Vickery J, Blaiss MS. Management of rhinitis: allergic and non-allergic. Allergy Asthma Immunol Res 2011; 3 (03) 148-156
- 8 Sur DK, Plesa ML. Treatment of Allergic Rhinitis. Am Fam Physician 2015; 92 (11) 985-992
- 9 Gawchik SM, Saccar CL. The use of nasal corticosteroids in allergic rhinitis. Pediatr Asthma Allergy Immunol 1995; 9 (01) 25-38
- 10 Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007; 28 (01) 3-9
- 11 Almutairi TA, Aldayel AA, Aldayel AS, Alotaibi F, Alhussain HA. Safety Concerns of Nasal Corticosteroids Usage in Patients With Allergic Rhinitis. Cureus 2020; 12 (11) e11651
- 12 Katelaris CH, Sacks R, Theron PN. Allergic rhinoconjunctivitis in the Australian population: burden of disease and attitudes to intranasal corticosteroid treatment. Am J Rhinol Allergy 2013; 27 (06) 506-509
- 13 Almatroudi A, Mousa AM, Vinnakota D. et al. Prevalence and associated factors of respiratory allergies in the Kingdom of Saudi Arabia: A cross-sectional investigation, September-December 2020. PLoS One 2021; 16 (06) e0253558
- 14 Mahnashi TA, Faqihi MA, Moafa AN. et al. Severity and prevalence of allergic rhinitis among school children, Jazan Region Saudi Arabia. J Family Med Prim Care 2019; 8 (02) 663-668
- 15 Rifaei SM, Etoom S, Hanandeh SA. et al. Public Awareness of Corticosteroid Use and Side Effects: a Cross-Sectional Study from Jordan. Mater Sociomed 2025; 37 (01) 24-31
- 16 Al-Rasheedi AN. Knowledge of, Attitudes towards, and Practices of Intranasal Corticosteroids Usage among the Allergic Rhinitis Patients of Northern Saudi Arabia: A Cross-Sectional Study. Healthcare (Basel) 2023; 11 (04) 537
- 17 Klimek L, Bachert C, Pfaar O. et al. ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergol Select 2019; 3 (01) 22-50
- 18 Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. PharmacoEconomics 2004; 22 (06) 345-361
- 19 Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet 2011; 378 (9809) 2112-2122